| |||||||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Chronic venous insufficiency (rutin) Hepatitis (catechin) Oedema (water retention) (coumarin, hydroxyethylrutosides) |
![]() |
Dysmenorrhoea (rutin plus vitamin B3 [niacin] and vitamin C) Gingivitis (periodontal disease) (in combination with vitamin C) Haemorrhoids (hydroxyethylrutosides derived from rutin) Ménière’s disease (hydroxyethylrutosides) Oedema (water retention) (diosmin and hesperidin combination) Skin ulcers (diosmin, hesperidin) |
![]() |
Atherosclerosis (quercetin, bilberry) Cancer (naringenin) Capillary fragility (hesperidin, quercetin, rutin) Cataracts (quercetin, bilberry) Gingivitis (periodontal disease) Glaucoma (rutin) Hay fever (quercetin, hesperidin, rutin) Macular degeneration (bilberry) Menopause (hesperidin) Menorrhagia (heavy menstruation) Oedema (water retention) (quercetin) Progressive pigmented purpura (in combination with vitamin C) Retinopathy (quercetin, rutin) |
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Flavonoid supplements are not required to prevent deficiencies in people eating a healthy diet. Healthcare practitioners commonly recommend 1,000 mg of citrus flavonoids taken one to three times per day. Alternatively, 240–600 mg of bilberry (standardized to 25% anthcyanosides) may be taken per day.
No consistent side effects have been linked to the flavonoids except for catechin, which can occasionally cause fever, anaemia from breakdown of red blood cells, and hives.4 5 These side effects subsided when treatment was discontinued.
In 1980, quercetin was reported to induce cancer in animals.6 Most further research did not find this to be true, however.7 8 While quercetin is mutagenic in test tube studies, it does not appear to be mutagenic in animal studies.9 In fact, quercetin has been found to inhibit both tumour promoters10 and human cancer cells.11 People who eat high levels of flavonoids have been found to have an overall lower risk of getting a wide variety of cancers,12 though preliminary human research studying only foods high in quercetin has found no relation to cancer risk one way or the other.13 Despite the confusion, in recent years experts have shifted their view of quercetin from concerns that it might cause cancer in test tube studies to guarded hope that quercetin has anticancer effects in humans.14
The flavonoids work in conjunction with vitamin C. Citrus flavonoids, in particular, improve the absorption of vitamin C.15 16
Are there any drug
interactions?
Certain medicines may interact with flavonoids. Refer to drug interactions for a list of those medicines.
1. Peterson J, Dwyer J. Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. J Am Diet Assoc 1998;98:682-5.
2. So FV, Guthrie N, Chambers AF, et al. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996;26:167-81.
3. Reinhold U, Seiter S, Ugurel S, Tilgen W. Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients. J Am Acad Dermatol 1999;41(2 Pt 1):207-8.
4. Bar-Meir S, Halpern Z, Gutman M, et al. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double-blind controlled trial. Gut 1985;26:975–9.
5. Conn HO. Cyanidanol: will a hepatotrophic drug from Europe go west? Hepatology 1983;3:121–3 [review].
6. Pamukcu AM, Yalciner S, Hatcher JF, Bryan GT. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res 1980;40:3468–72.
7. Hirono I, Ueno I, Hosaka S, et al. Carcinogenicity examination of quercetin and rutin in ACI rats. Cancer Lett 1981;13:15–21.
8. Saito D, Shirai A, Matsushima T, et al. Test of carcinogenicity of quercetin, a widely distributed mutagen in food. Teratog Carcinog Mutagen 1980;1:213–21.
9. Aeschbacher H-U, Meier H, Ruch E. Nonmutagenicity in vivo of the food flavonol quercetin. Nutr Cancer 1982;2:90.
10. Nishino H, Nishino A, Iwashima A, et al. Quercetin inhibits the action of 12-O-tetradecanoylphorbol-13-acetate, a tumor promoter. Oncology 1984;41:120–3.
11. Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996;110:41–8.
12. Knekt P, Jävinen R, Seppänen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223–30.
13. Hertog M, Feskens EJM, Hollman PCH, et al. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 1994;22:175–84.
14. Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin Biochem 1994;27:245–8.
15. Vinson JA, Bose P. Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract. Am J Clin Nutr 1988;48:601–4.
16. Vinson JA, Bose P. Comparative bioavailability of synthetic and natural vitamin C in guinea pigs. Nutr Rep Int 1983;27:875–9.
| |||||||